Pharmacology  ·  Local Anesthetics

Systemic Toxicity, Methemoglobinemia, and Special Considerations

Toxicity progression, lipid emulsion rescue, methemoglobinemia, and special populations

• Local anesthetic systemic toxicity follows a predictable anatomical sequence that reflects the relative sensitivity of the central nervous system versus the cardiovascular system to sodium channel blockade. The CNS is affected first — and at lower plasma concentrations — because neurons are more easily depolarized than cardiomyocytes. That sequence means early CNS symptoms are both the warning signal and the window for intervention before cardiovascular collapse.
• The early CNS symptoms — circumoral numbness, metallic taste, tinnitus — are the examination anchor for this sequence. They appear before agitation, before seizures, and well before the cardiac phase. Recognizing them as prodromal rather than benign is the clinical skill the module is testing. The treatment card across from the sequence card shows that stopping the injection at the first sign is the most effective intervention available.
• Intravenous lipid emulsion works through a mechanism called "lipid sink" — the fatty emulsion creates a separate lipid phase in the blood that sequesters the highly lipid-soluble local anesthetic away from cardiac tissue. For bupivacaine in particular, where the cardiac sodium channel blockade is both dense and slow to reverse, lipid emulsion is the specific pharmacological antidote. The rule box reinforces that bupivacaine cardiac arrest requires prolonged resuscitation and early abandonment is a mistake.
• Methemoglobinemia from prilocaine and benzocaine was introduced in Module 2 as a toxicological fact. This module provides the mechanism and treatment. The pulse oximetry limitation is a second examination anchor: the meter reads approximately 85% regardless of the actual methemoglobin fraction because it cannot distinguish between oxyhemoglobin and methemoglobin by light absorption. The diagnosis requires co-oximetry, and the chocolate-brown color of the blood is the clinical clue.
• The three special population cards close the chapter by applying the amide/ester metabolism distinction from Module 2 to specific clinical situations. Liver disease impairs amide clearance — switch to esters. Pseudocholinesterase deficiency impairs ester clearance — switch to amides. Pregnancy introduces ion trapping in the fetal circulation, which is directly derived from the ionization principle established in Module 1. The chapter ends where it began — with the chemistry of ionization determining clinical outcome.